<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-74282</identifier>
<setSpec>0214-1582</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Subcutaneous mastectomy has been studied as an alternativesurgical treatment to conventional total mastectomy in thosepatients, diagnosed of ductal carcinoma in situ (DCIS). Subcutaneousmastectomy has been performed in 82 women withimmediate reconstruction. With a median follow-up of 86,3months, 8 recurrences have been diagnosed.Subcutaneous mastectomy may be a good and acceptedtreatment option in cases were radical surgery is needed withan intermediate local failure rate(AU)</dc:description>
<dc:creator>Giménez-Climent, M. J</dc:creator>
<dc:creator>Sancho, F</dc:creator>
<dc:creator>Vázquez, C</dc:creator>
<dc:creator>Martínez-Carsí, C</dc:creator>
<dc:creator>Llopis, F</dc:creator>
<dc:creator>Almenar, S</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se estudia la adenomastectomía (ADM) como alternativaterapéutica a la mastectomía simple en carcinoma ductal insitu (CDIS).Ochenta y dos pacientes diagnosticadas de CDIS con indicaciónde mastectomía, han sido tratadas con ADM y reconstruccióninmediata. Con una mediana de seguimiento de86,33 meses, se han diagnosticado 8 recidivas.La ADM puede ser una opción menos agresiva y estéticamentemejor aceptada en los casos de CDIS, con una tasa derecaídas locales intermedia entre la de la mastectomía simple yel tratamiento conservador(AU)</dc:description>
<dc:source>Rev. senol. patol. mamar. (Ed. impr.);20(3): 108-114, 2007. tab, ilus</dc:source>
<dc:identifier>ibc-74282</dc:identifier>
<dc:title xml:lang="es">¿Es la adenomastectomía una alternativa a la mastectomía total en el carcinoma ductal in situ no tributario de tratamiento conservador?</dc:title>
<dc:subject>^d331</dc:subject>
<dc:subject>^d2148^s22012</dc:subject>
<dc:subject>^d244^s22009</dc:subject>
<dc:subject>^d1732^s22074</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2148^s22009</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d8580^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d31593^s22009</dc:subject>
<dc:subject>^d9572^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>200700</dc:date>
</metadata>
</record>
</ibecs-document>
